Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.
As biotech VCs struggle to raise money, some debate whether the worst is over
Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists. Representatives from
January 25, 2024